Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
868.00 GBX | 0.00% |
|
+0.12% | +7.29% |
06-09 | Macquarie Unit, Canadian Investor Complete Acquisition of European Recycling Firm | MT |
06-09 | Renewi Delists from Euronext Amsterdam, London Bourse | MT |
Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.34 | 2.22 | 4.05 | 4.19 | 3.01 | |||||
Return on Total Capital | 4.36 | 4.22 | 8.01 | 8.06 | 5.92 | |||||
Return On Equity % | -21.81 | 4.6 | 26.19 | 19.33 | 13.67 | |||||
Return on Common Equity | -22.19 | 4.71 | 26.48 | 18.72 | 13.16 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 17.08 | 16.64 | 18.9 | 18.18 | 19.68 | |||||
SG&A Margin | 12.02 | 11.48 | 11.35 | 10.35 | 12.95 | |||||
EBITDA Margin % | 8.87 | 8.95 | 10.74 | 11.17 | 10.72 | |||||
EBITA Margin % | 4.75 | 4.56 | 7.04 | 7.49 | 6.62 | |||||
EBIT Margin % | 4.31 | 4.29 | 6.79 | 7.14 | 5.9 | |||||
Income From Continuing Operations Margin % | -3.41 | 0.65 | 4.03 | 3.52 | 2.68 | |||||
Net Income Margin % | -4.39 | 0.66 | 3.99 | 3.32 | -2.02 | |||||
Net Avail. For Common Margin % | -3.45 | 0.66 | 3.99 | 3.32 | 2.49 | |||||
Normalized Net Income Margin | 1.56 | 1.74 | 3.25 | 3.34 | 2.12 | |||||
Levered Free Cash Flow Margin | 10.92 | 6.79 | 2.64 | 3.89 | 12.55 | |||||
Unlevered Free Cash Flow Margin | 12.05 | 7.82 | 3.54 | 4.78 | 13.57 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.87 | 0.83 | 0.95 | 0.94 | 0.82 | |||||
Fixed Assets Turnover | 2.5 | 2.12 | 2.39 | 2.31 | 1.94 | |||||
Receivables Turnover (Average Receivables) | 10.43 | 10.93 | 12.66 | 11.21 | 10.4 | |||||
Inventory Turnover (Average Inventory) | 63.05 | 68.37 | 70.34 | 64.92 | 55.84 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.79 | 0.52 | 0.53 | 0.6 | 0.54 | |||||
Quick Ratio | 0.73 | 0.46 | 0.43 | 0.51 | 0.35 | |||||
Operating Cash Flow to Current Liabilities | 0.25 | 0.38 | 0.25 | 0.28 | 0.18 | |||||
Days Sales Outstanding (Average Receivables) | 35.09 | 33.38 | 28.83 | 32.57 | 35.2 | |||||
Days Outstanding Inventory (Average Inventory) | 5.8 | 5.34 | 5.19 | 5.62 | 6.55 | |||||
Average Days Payable Outstanding | 47.71 | 41.41 | 30.55 | 28.06 | 36.02 | |||||
Cash Conversion Cycle (Average Days) | -6.81 | -2.69 | 3.47 | 10.13 | 5.73 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 401.36 | 296.01 | 197.4 | 215.49 | 221.34 | |||||
Total Debt / Total Capital | 80.05 | 74.75 | 66.38 | 68.3 | 68.88 | |||||
LT Debt/Equity | 383.89 | 277.21 | 153.37 | 196.26 | 182.93 | |||||
Long-Term Debt / Total Capital | 76.57 | 70 | 51.57 | 62.21 | 56.93 | |||||
Total Liabilities / Total Assets | 88.9 | 87.57 | 82.67 | 83.35 | 84.73 | |||||
EBIT / Interest Expense | 2.25 | 2.41 | 4.23 | 4.71 | 3.4 | |||||
EBITDA / Interest Expense | 5.59 | 6.39 | 8.19 | 8.99 | 7.94 | |||||
(EBITDA - Capex) / Interest Expense | 3.22 | 4.46 | 5.6 | 4.99 | 5 | |||||
Total Debt / EBITDA | 4.97 | 3.74 | 2.72 | 2.9 | 2.99 | |||||
Net Debt / EBITDA | 3.91 | 3.43 | 2.5 | 2.69 | 2.65 | |||||
Total Debt / (EBITDA - Capex) | 8.62 | 5.36 | 3.97 | 5.23 | 4.74 | |||||
Net Debt / (EBITDA - Capex) | 6.77 | 4.91 | 3.65 | 4.85 | 4.2 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -0.3 | -4.61 | 10.37 | 1.24 | -0.86 | |||||
Gross Profit, 1 Yr. Growth % | -0.23 | -7.06 | 25.37 | -2.63 | -4.24 | |||||
EBITDA, 1 Yr. Growth % | -10.92 | 16.63 | 39.25 | 5.23 | -12.85 | |||||
EBITA, 1 Yr. Growth % | -3.1 | 36.09 | 87.86 | 7.83 | -19.03 | |||||
EBIT, 1 Yr. Growth % | -3.89 | 48.16 | 94.33 | 6.54 | -22.13 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -21.02 | -118.18 | 1.27K | -11.67 | -47.44 | |||||
Net Income, 1 Yr. Growth % | -16.06 | -114.25 | 1.23K | -15.57 | -154.21 | |||||
Normalized Net Income, 1 Yr. Growth % | -27.2 | 184.36 | 143.39 | 4.03 | -39.88 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -14.31 | -118.09 | 1.23K | -15.05 | -49.16 | |||||
Accounts Receivable, 1 Yr. Growth % | 4.57 | -21.95 | 17.45 | 11.72 | -17.68 | |||||
Inventory, 1 Yr. Growth % | -20.38 | -0.48 | 9.22 | 12 | -7.14 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 25.72 | -0.68 | -3.41 | 13.5 | 0.18 | |||||
Total Assets, 1 Yr. Growth % | 7.46 | -8.12 | -0.82 | 6.85 | -1.4 | |||||
Tangible Book Value, 1 Yr. Growth % | 31.03 | -2.92 | -28.01 | 15.98 | 11.17 | |||||
Common Equity, 1 Yr. Growth % | -26.56 | 1.33 | 43.07 | 0.69 | -10.74 | |||||
Cash From Operations, 1 Yr. Growth % | 114.27 | 54.34 | -24.42 | 4.84 | -10.46 | |||||
Capital Expenditures, 1 Yr. Growth % | -21.1 | -27.86 | 33.79 | 48.2 | -25.13 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -344.08 | -34.87 | -49.58 | 46.07 | 193.39 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -433.2 | -32.68 | -42.53 | 34.65 | 167.39 | |||||
Dividend Per Share, 1 Yr. Growth % | -69.7 | - | - | - | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 0.43 | -2.48 | 2.61 | 5.7 | -4.94 | |||||
Gross Profit, 2 Yr. CAGR % | -3.66 | -3.7 | 7.95 | 10.49 | -3 | |||||
EBITDA, 2 Yr. CAGR % | -8.28 | -7.43 | 24.33 | 21.05 | -5.03 | |||||
EBITA, 2 Yr. CAGR % | -6.96 | -5.79 | 52.16 | 42.33 | -7.75 | |||||
EBIT, 2 Yr. CAGR % | -1.72 | -4.56 | 60.93 | 43.89 | -11.41 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 8.49 | -62.1 | 11.64 | 247.98 | -22.57 | |||||
Net Income, 2 Yr. CAGR % | 19.89 | -65.42 | -2.21 | 235.14 | -32.35 | |||||
Normalized Net Income, 2 Yr. CAGR % | -13.66 | -11.79 | 141.91 | 59.12 | -23.26 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 8.92 | -60.63 | 9.82 | 235.94 | -24.72 | |||||
Accounts Receivable, 2 Yr. CAGR % | -4.85 | -9.66 | -4.26 | 14.55 | -4.1 | |||||
Inventory, 2 Yr. CAGR % | -11.78 | -10.99 | 4.26 | 10.6 | 1.98 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 5.48 | 12.38 | -2.05 | 4.7 | 6.63 | |||||
Total Assets, 2 Yr. CAGR % | 0.78 | -0.42 | -4.25 | 2.94 | 2.64 | |||||
Tangible Book Value, 2 Yr. CAGR % | 18.24 | 12.78 | -16.61 | -9.28 | 13.55 | |||||
Common Equity, 2 Yr. CAGR % | -26.26 | -13.74 | 19 | 20.69 | -5.2 | |||||
Cash From Operations, 2 Yr. CAGR % | 7.68 | 81.85 | 6.96 | -11.16 | -3.11 | |||||
Capital Expenditures, 2 Yr. CAGR % | -4.47 | -24.56 | -1.76 | 40.81 | 5.33 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 45.1 | 20.34 | -47.14 | -13.32 | 105.14 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 40.71 | 43.61 | -41.97 | -11.37 | 84.68 | |||||
Dividend Per Share, 2 Yr. CAGR % | -61.69 | - | - | - | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 26.22 | -1.28 | 1.63 | 2.15 | -0.09 | |||||
Gross Profit, 3 Yr. CAGR % | 29.3 | -4.81 | 5.15 | 4.3 | 5.66 | |||||
EBITDA, 3 Yr. CAGR % | 20.58 | -6.81 | 4.33 | 17.61 | 7.89 | |||||
EBITA, 3 Yr. CAGR % | 25.71 | -7.45 | 14.72 | 35.66 | 16.93 | |||||
EBIT, 3 Yr. CAGR % | 25.75 | -2.9 | 16.77 | 40.26 | 15.11 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -4.29 | -40.19 | -0.52 | 3.25 | 101.8 | |||||
Net Income, 3 Yr. CAGR % | 4.01 | -41.06 | -7.06 | -6.88 | 82.61 | |||||
Normalized Net Income, 3 Yr. CAGR % | 17.63 | -7.3 | 16.99 | 82.59 | 12.75 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -15.55 | -40.12 | 1.1 | 0.81 | 95.99 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.95 | -10.93 | -1.4 | 0.8 | 2.61 | |||||
Inventory, 3 Yr. CAGR % | -2.81 | -8.17 | -4.71 | 6.78 | 4.34 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 4.26 | 3.78 | 6.85 | 2.88 | 3.17 | |||||
Total Assets, 3 Yr. CAGR % | 1.67 | -2.14 | -0.36 | -0.69 | 1.47 | |||||
Tangible Book Value, 3 Yr. CAGR % | 29.53 | 10.71 | -3.05 | -7.36 | -2.92 | |||||
Common Equity, 3 Yr. CAGR % | -21.87 | -18.02 | 1.31 | 12.97 | 9.15 | |||||
Cash From Operations, 3 Yr. CAGR % | 83.3 | 21.41 | 34.83 | 6.11 | -10.93 | |||||
Capital Expenditures, 3 Yr. CAGR % | 23.04 | -13.01 | -8.68 | 12.67 | 14.08 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 10.34 | 7.7 | -14.67 | -25.33 | 29.36 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 10.91 | 7.01 | 1.04 | -22.79 | 25.78 | |||||
Dividend Per Share, 3 Yr. CAGR % | -47.15 | - | - | - | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 21.19 | 18.64 | 15.18 | 1.46 | -1.05 | |||||
Gross Profit, 5 Yr. CAGR % | 23.97 | 20.58 | 19.25 | 1.04 | 1.81 | |||||
EBITDA, 5 Yr. CAGR % | 15.01 | 14.18 | 16.43 | 2.45 | 0.48 | |||||
EBITA, 5 Yr. CAGR % | 17.47 | 14.61 | 24.27 | 7.78 | 5.14 | |||||
EBIT, 5 Yr. CAGR % | 17.73 | 15.49 | 25.83 | 11.26 | 4.56 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 24.02 | 18.56 | 0.91 | 5.32 | -10.01 | |||||
Net Income, 5 Yr. CAGR % | 32.24 | 19.38 | 0.6 | 3.02 | -18.15 | |||||
Normalized Net Income, 5 Yr. CAGR % | 12.11 | 17.21 | 27.94 | 11.27 | -1.17 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 8.15 | 5.72 | -7 | 3.98 | -10.15 | |||||
Accounts Receivable, 5 Yr. CAGR % | 7.66 | 8.63 | -2.02 | -1.5 | -2.49 | |||||
Inventory, 5 Yr. CAGR % | 21.5 | 20.88 | -0.91 | -1.08 | -2.09 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 19.8 | 17.91 | 1.04 | 4.15 | 6.76 | |||||
Total Assets, 5 Yr. CAGR % | 14.25 | 14.49 | -1.52 | -0.02 | 0.83 | |||||
Tangible Book Value, 5 Yr. CAGR % | 80.98 | 100.1 | 7.67 | 2.14 | 2.98 | |||||
Common Equity, 5 Yr. CAGR % | 1.58 | 1.79 | -8.35 | -4.75 | -1.12 | |||||
Cash From Operations, 5 Yr. CAGR % | 22.68 | 25.2 | 46.49 | 6.74 | 18.04 | |||||
Capital Expenditures, 5 Yr. CAGR % | 12.72 | 10.87 | 11.47 | 5.47 | -3.31 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 51.69 | 14.31 | -20.01 | -4.4 | 21.68 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 97.94 | 11.37 | -16.56 | -3.48 | 28.99 | |||||
Dividend Per Share, 5 Yr. CAGR % | -33.46 | - | - | - | -19.04 |
- Stock Market
- Equities
- SKS Stock
- Financials Renewi plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition